Salvage Regimens Containing Darunavir, Etravirine, Raltegravir, Or Enfuvirtide In Highly Treatment-Experienced Perinatally Infected Pregnant Women

Combination antiretroviral therapy in pregnant women with human immunodeficiency virus has dramatically decreased maternal-to-child transmission. Highly treatment-experienced pregnant patients have limited effective treatment options due to past toxicities and viral resistance. We present 8 pregnancies in 7 perinatally infected women successfully treated with salvage regimens containing darunavir, etravirine, raltegravir, or enfuvirtide.